 Wei Perng
Concepts (372)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 29 | 2023 | 516 | 7.620 |
Why?
| | Prenatal Exposure Delayed Effects | 17 | 2022 | 468 | 5.570 |
Why?
| | Body Mass Index | 46 | 2024 | 2092 | 4.420 |
Why?
| | Pediatric Obesity | 13 | 2023 | 524 | 3.480 |
Why?
| | Diabetes, Gestational | 9 | 2023 | 283 | 3.380 |
Why?
| | Environmental Pollutants | 7 | 2022 | 120 | 3.100 |
Why?
| | Birth Weight | 16 | 2023 | 465 | 2.820 |
Why?
| | Pregnancy | 56 | 2024 | 5690 | 2.800 |
Why?
| | Non-alcoholic Fatty Liver Disease | 8 | 2023 | 280 | 2.700 |
Why?
| | Biomarkers | 25 | 2023 | 3588 | 2.640 |
Why?
| | Weight Gain | 11 | 2023 | 493 | 2.630 |
Why?
| | Diet | 17 | 2023 | 1153 | 2.580 |
Why?
| | Metabolomics | 12 | 2024 | 550 | 2.290 |
Why?
| | Cardiovascular Diseases | 10 | 2023 | 1798 | 2.280 |
Why?
| | Obesity | 24 | 2024 | 2746 | 2.220 |
Why?
| | Body Composition | 15 | 2023 | 653 | 2.140 |
Why?
| | Leptin | 9 | 2023 | 231 | 2.110 |
Why?
| | Endocrine Disruptors | 3 | 2021 | 35 | 2.080 |
Why?
| | Mothers | 8 | 2024 | 682 | 1.950 |
Why?
| | Child | 69 | 2024 | 19129 | 1.950 |
Why?
| | Epigenesis, Genetic | 7 | 2023 | 539 | 1.820 |
Why?
| | DNA Methylation | 8 | 2023 | 503 | 1.780 |
Why?
| | Insulin | 8 | 2023 | 2162 | 1.770 |
Why?
| | Environmental Exposure | 6 | 2022 | 405 | 1.760 |
Why?
| | Metabolic Syndrome | 5 | 2021 | 394 | 1.740 |
Why?
| | Female | 99 | 2024 | 61564 | 1.680 |
Why?
| | Overnutrition | 3 | 2021 | 39 | 1.640 |
Why?
| | Overweight | 8 | 2024 | 502 | 1.640 |
Why?
| | Body Weight | 7 | 2022 | 934 | 1.550 |
Why?
| | Child Health | 3 | 2023 | 137 | 1.540 |
Why?
| | Infant, Newborn | 29 | 2023 | 5255 | 1.520 |
Why?
| | Stress, Psychological | 3 | 2023 | 972 | 1.510 |
Why?
| | Premature Birth | 6 | 2022 | 284 | 1.490 |
Why?
| | Prospective Studies | 29 | 2023 | 6471 | 1.490 |
Why?
| | Hypertension, Pregnancy-Induced | 5 | 2022 | 46 | 1.440 |
Why?
| | Humans | 120 | 2024 | 118972 | 1.400 |
Why?
| | Body Height | 5 | 2018 | 187 | 1.380 |
Why?
| | Adolescent | 41 | 2023 | 18480 | 1.370 |
Why?
| | Long Interspersed Nucleotide Elements | 3 | 2013 | 23 | 1.360 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2174 | 1.320 |
Why?
| | Metabolome | 4 | 2020 | 296 | 1.310 |
Why?
| | Pregnancy Outcome | 5 | 2022 | 349 | 1.300 |
Why?
| | Waist Circumference | 9 | 2022 | 130 | 1.230 |
Why?
| | Health Status | 2 | 2023 | 726 | 1.160 |
Why?
| | Child, Preschool | 35 | 2024 | 9491 | 1.150 |
Why?
| | Metabolic Diseases | 4 | 2021 | 103 | 1.110 |
Why?
| | Mexico | 11 | 2023 | 165 | 1.080 |
Why?
| | Nutritional Status | 4 | 2020 | 300 | 1.080 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2022 | 32 | 1.080 |
Why?
| | Risk Factors | 23 | 2023 | 9000 | 1.080 |
Why?
| | Puberty | 4 | 2022 | 144 | 1.070 |
Why?
| | Cohort Studies | 20 | 2023 | 5116 | 1.030 |
Why?
| | Male | 60 | 2023 | 57801 | 1.020 |
Why?
| | Blood Glucose | 9 | 2023 | 1939 | 1.010 |
Why?
| | C-Reactive Protein | 7 | 2017 | 360 | 0.970 |
Why?
| | Skinfold Thickness | 4 | 2018 | 46 | 0.970 |
Why?
| | Fluorocarbons | 2 | 2022 | 105 | 0.970 |
Why?
| | Maternal Nutritional Physiological Phenomena | 4 | 2023 | 157 | 0.950 |
Why?
| | Child Development | 6 | 2023 | 410 | 0.950 |
Why?
| | Insulin Resistance | 8 | 2021 | 1180 | 0.910 |
Why?
| | Psychological Tests | 1 | 2023 | 129 | 0.890 |
Why?
| | Lead | 2 | 2021 | 47 | 0.890 |
Why?
| | Fetal Blood | 3 | 2022 | 272 | 0.880 |
Why?
| | Anti-Mullerian Hormone | 1 | 2023 | 51 | 0.880 |
Why?
| | Self Report | 4 | 2023 | 699 | 0.870 |
Why?
| | Sexual Maturation | 2 | 2019 | 51 | 0.850 |
Why?
| | Azocines | 1 | 2021 | 4 | 0.830 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 38 | 0.830 |
Why?
| | Hyaenidae | 1 | 2021 | 1 | 0.820 |
Why?
| | Blood Pressure | 7 | 2022 | 1664 | 0.820 |
Why?
| | Insulins | 1 | 2022 | 34 | 0.820 |
Why?
| | Ecology | 1 | 2022 | 104 | 0.810 |
Why?
| | Adiponectin | 4 | 2023 | 226 | 0.810 |
Why?
| | Cardiovascular System | 1 | 2023 | 127 | 0.800 |
Why?
| | Phthalic Acids | 2 | 2022 | 29 | 0.800 |
Why?
| | Maternal Behavior | 1 | 2021 | 64 | 0.790 |
Why?
| | Biological Evolution | 2 | 2022 | 443 | 0.760 |
Why?
| | Adult | 30 | 2023 | 31512 | 0.750 |
Why?
| | Hyperinsulinism | 1 | 2021 | 107 | 0.750 |
Why?
| | Triglycerides | 7 | 2023 | 519 | 0.740 |
Why?
| | Racism | 1 | 2022 | 102 | 0.740 |
Why?
| | Prediabetic State | 1 | 2023 | 234 | 0.720 |
Why?
| | Placenta | 3 | 2023 | 638 | 0.720 |
Why?
| | Lipids | 3 | 2020 | 607 | 0.710 |
Why?
| | Young Adult | 20 | 2023 | 10793 | 0.710 |
Why?
| | Social Environment | 1 | 2021 | 294 | 0.700 |
Why?
| | Infant | 22 | 2024 | 8293 | 0.700 |
Why?
| | Islets of Langerhans | 2 | 2023 | 739 | 0.680 |
Why?
| | Epidemiology | 1 | 2018 | 15 | 0.670 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2018 | 77 | 0.640 |
Why?
| | Longitudinal Studies | 12 | 2023 | 2513 | 0.640 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2018 | 10 | 0.630 |
Why?
| | Cholesterol | 4 | 2023 | 373 | 0.630 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2018 | 48 | 0.630 |
Why?
| | Adipose Tissue | 5 | 2020 | 606 | 0.630 |
Why?
| | Homeostasis | 2 | 2021 | 594 | 0.620 |
Why?
| | Linear Models | 8 | 2024 | 827 | 0.620 |
Why?
| | Body Fluid Compartments | 1 | 2017 | 6 | 0.620 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2017 | 24 | 0.620 |
Why?
| | Sex Characteristics | 2 | 2020 | 671 | 0.620 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 38 | 0.610 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2018 | 125 | 0.590 |
Why?
| | Androgens | 1 | 2018 | 167 | 0.570 |
Why?
| | Bone and Bones | 1 | 2019 | 289 | 0.570 |
Why?
| | Maternal Exposure | 2 | 2020 | 142 | 0.570 |
Why?
| | Feeding Behavior | 3 | 2023 | 601 | 0.560 |
Why?
| | Breast Feeding | 4 | 2024 | 386 | 0.560 |
Why?
| | MicroRNAs | 1 | 2022 | 637 | 0.550 |
Why?
| | Anthropometry | 6 | 2022 | 194 | 0.550 |
Why?
| | Fetal Development | 1 | 2018 | 250 | 0.540 |
Why?
| | Diabetes Mellitus | 2 | 2023 | 942 | 0.530 |
Why?
| | Micronutrients | 2 | 2013 | 79 | 0.520 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 287 | 0.520 |
Why?
| | Maternal Welfare | 1 | 2014 | 15 | 0.510 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 8 | 0.510 |
Why?
| | Colombia | 6 | 2018 | 43 | 0.500 |
Why?
| | Inflammation | 4 | 2022 | 2566 | 0.490 |
Why?
| | Alu Elements | 1 | 2013 | 21 | 0.480 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 24 | 0.480 |
Why?
| | Abdominal Fat | 3 | 2023 | 48 | 0.460 |
Why?
| | Homocysteine | 1 | 2013 | 137 | 0.460 |
Why?
| | Iron, Dietary | 1 | 2013 | 19 | 0.450 |
Why?
| | Intra-Abdominal Fat | 3 | 2023 | 98 | 0.450 |
Why?
| | Fatty Acids | 2 | 2020 | 407 | 0.440 |
Why?
| | Growth Disorders | 1 | 2013 | 77 | 0.440 |
Why?
| | Follow-Up Studies | 8 | 2022 | 4596 | 0.430 |
Why?
| | Poliomyelitis | 1 | 2012 | 30 | 0.420 |
Why?
| | Postpartum Period | 3 | 2020 | 271 | 0.420 |
Why?
| | Infertility | 2 | 2022 | 45 | 0.420 |
Why?
| | Endotoxins | 2 | 2023 | 234 | 0.420 |
Why?
| | Sex Factors | 4 | 2019 | 1781 | 0.410 |
Why?
| | Socioeconomic Factors | 6 | 2016 | 1129 | 0.400 |
Why?
| | Diseases in Twins | 1 | 2012 | 181 | 0.390 |
Why?
| | Twins | 1 | 2012 | 247 | 0.380 |
Why?
| | Causality | 2 | 2021 | 109 | 0.370 |
Why?
| | Atherosclerosis | 1 | 2013 | 345 | 0.370 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2023 | 3360 | 0.360 |
Why?
| | Hypertension | 2 | 2015 | 1203 | 0.360 |
Why?
| | Age of Onset | 2 | 2022 | 467 | 0.350 |
Why?
| | C-Peptide | 2 | 2021 | 137 | 0.350 |
Why?
| | Gestational Age | 3 | 2023 | 765 | 0.330 |
Why?
| | Principal Component Analysis | 3 | 2019 | 180 | 0.320 |
Why?
| | Fatty Liver | 2 | 2021 | 253 | 0.320 |
Why?
| | Boston | 3 | 2018 | 76 | 0.320 |
Why?
| | Logistic Models | 3 | 2023 | 1901 | 0.310 |
Why?
| | Massachusetts | 2 | 2019 | 141 | 0.300 |
Why?
| | Interleukin-6 | 3 | 2014 | 688 | 0.290 |
Why?
| | Cross-Sectional Studies | 6 | 2021 | 4552 | 0.290 |
Why?
| | Liver | 3 | 2023 | 1816 | 0.270 |
Why?
| | Multivariate Analysis | 5 | 2016 | 1474 | 0.270 |
Why?
| | Regression Analysis | 3 | 2018 | 983 | 0.270 |
Why?
| | Air Pollution | 2 | 2020 | 209 | 0.270 |
Why?
| | Incidence | 3 | 2023 | 2424 | 0.260 |
Why?
| | Odds Ratio | 3 | 2023 | 996 | 0.260 |
Why?
| | Hyperglycemia | 2 | 2018 | 312 | 0.260 |
Why?
| | Air Pollutants | 2 | 2020 | 316 | 0.250 |
Why?
| | Health Behavior | 3 | 2021 | 720 | 0.250 |
Why?
| | Genetic Association Studies | 2 | 2019 | 371 | 0.250 |
Why?
| | Pregnancy Complications | 3 | 2020 | 448 | 0.250 |
Why?
| | Colorado | 4 | 2023 | 4196 | 0.240 |
Why?
| | Birth Order | 1 | 2023 | 13 | 0.230 |
Why?
| | Asthma | 4 | 2023 | 2158 | 0.230 |
Why?
| | Parturition | 2 | 2022 | 53 | 0.230 |
Why?
| | Phenotype | 2 | 2022 | 3003 | 0.220 |
Why?
| | Age Factors | 3 | 2019 | 2995 | 0.220 |
Why?
| | Menopause | 2 | 2022 | 266 | 0.220 |
Why?
| | Vegetables | 2 | 2020 | 133 | 0.220 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 32 | 0.210 |
Why?
| | Michigan | 2 | 2020 | 95 | 0.210 |
Why?
| | Alkanesulfonic Acids | 1 | 2022 | 33 | 0.210 |
Why?
| | Lysine | 1 | 2024 | 248 | 0.210 |
Why?
| | Pregnant Women | 1 | 2023 | 132 | 0.210 |
Why?
| | Cholesterol, LDL | 2 | 2022 | 316 | 0.210 |
Why?
| | Hand Strength | 1 | 2022 | 99 | 0.200 |
Why?
| | Carbohydrates | 1 | 2021 | 59 | 0.200 |
Why?
| | Toxoplasmosis, Animal | 1 | 2021 | 5 | 0.200 |
Why?
| | Plethysmography | 2 | 2022 | 124 | 0.200 |
Why?
| | American Heart Association | 1 | 2023 | 270 | 0.200 |
Why?
| | Antibodies, Protozoan | 1 | 2021 | 28 | 0.200 |
Why?
| | Toxoplasma | 1 | 2021 | 34 | 0.200 |
Why?
| | Latin America | 1 | 2021 | 74 | 0.200 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2023 | 499 | 0.200 |
Why?
| | Cats | 1 | 2021 | 205 | 0.200 |
Why?
| | Sarcopenia | 1 | 2022 | 72 | 0.190 |
Why?
| | Protective Factors | 1 | 2021 | 92 | 0.190 |
Why?
| | Selection, Genetic | 1 | 2022 | 252 | 0.190 |
Why?
| | Middle Aged | 9 | 2023 | 27617 | 0.190 |
Why?
| | Scotland | 1 | 2019 | 12 | 0.180 |
Why?
| | Problem Behavior | 1 | 2021 | 85 | 0.180 |
Why?
| | Pre-Eclampsia | 1 | 2022 | 183 | 0.180 |
Why?
| | Precision Medicine | 1 | 2023 | 363 | 0.180 |
Why?
| | Health Surveys | 1 | 2021 | 454 | 0.170 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 368 | 0.170 |
Why?
| | Fasting | 1 | 2020 | 264 | 0.170 |
Why?
| | Acetylcarnitine | 1 | 2018 | 4 | 0.170 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 336 | 0.170 |
Why?
| | Pilot Projects | 1 | 2023 | 1419 | 0.170 |
Why?
| | Aminoisobutyric Acids | 1 | 2018 | 8 | 0.170 |
Why?
| | Hydroxyproline | 1 | 2018 | 24 | 0.170 |
Why?
| | Feces | 1 | 2021 | 396 | 0.170 |
Why?
| | Ornithine | 1 | 2018 | 22 | 0.170 |
Why?
| | Asparagine | 1 | 2018 | 30 | 0.170 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 870 | 0.170 |
Why?
| | Milk, Human | 1 | 2020 | 145 | 0.160 |
Why?
| | Carnitine | 1 | 2018 | 65 | 0.160 |
Why?
| | Models, Theoretical | 1 | 2022 | 556 | 0.160 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 260 | 0.160 |
Why?
| | Phospholipids | 1 | 2019 | 208 | 0.160 |
Why?
| | Infant, Small for Gestational Age | 1 | 2018 | 73 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 233 | 0.160 |
Why?
| | Immunoglobulin G | 1 | 2022 | 788 | 0.160 |
Why?
| | History, 21st Century | 1 | 2018 | 170 | 0.160 |
Why?
| | Comorbidity | 1 | 2023 | 1527 | 0.160 |
Why?
| | Economic Development | 1 | 2017 | 3 | 0.160 |
Why?
| | Energy Metabolism | 2 | 2021 | 767 | 0.160 |
Why?
| | Mass Spectrometry | 2 | 2018 | 681 | 0.150 |
Why?
| | Health Promotion | 1 | 2023 | 691 | 0.150 |
Why?
| | Snacks | 2 | 2015 | 17 | 0.150 |
Why?
| | Glucocorticoids | 1 | 2021 | 545 | 0.150 |
Why?
| | Mexican Americans | 1 | 2017 | 100 | 0.140 |
Why?
| | Dietary Fats | 2 | 2018 | 322 | 0.140 |
Why?
| | Anxiety | 1 | 2022 | 845 | 0.140 |
Why?
| | Glucose Tolerance Test | 1 | 2017 | 368 | 0.140 |
Why?
| | Cognition | 1 | 2023 | 1024 | 0.140 |
Why?
| | Developing Countries | 1 | 2017 | 255 | 0.140 |
Why?
| | Trans Fatty Acids | 1 | 2015 | 6 | 0.140 |
Why?
| | Prehypertension | 1 | 2015 | 27 | 0.140 |
Why?
| | Glucose | 1 | 2021 | 953 | 0.140 |
Why?
| | Prognosis | 3 | 2021 | 3443 | 0.130 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 229 | 0.130 |
Why?
| | Risk | 1 | 2018 | 853 | 0.130 |
Why?
| | Pregnancy Trimesters | 1 | 2014 | 13 | 0.130 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2015 | 98 | 0.130 |
Why?
| | Urban Population | 1 | 2017 | 409 | 0.130 |
Why?
| | Aging | 2 | 2023 | 1670 | 0.130 |
Why?
| | Body Weights and Measures | 1 | 2014 | 35 | 0.130 |
Why?
| | Infant, Premature | 1 | 2018 | 480 | 0.130 |
Why?
| | Mitochondria | 1 | 2020 | 786 | 0.120 |
Why?
| | Exercise | 2 | 2023 | 1657 | 0.120 |
Why?
| | Los Angeles | 1 | 2013 | 60 | 0.120 |
Why?
| | New York City | 1 | 2013 | 75 | 0.120 |
Why?
| | Adaptation, Physiological | 1 | 2018 | 502 | 0.120 |
Why?
| | Pediatrics | 2 | 2018 | 985 | 0.120 |
Why?
| | Carbonated Beverages | 1 | 2013 | 19 | 0.120 |
Why?
| | Iron Overload | 1 | 2013 | 10 | 0.110 |
Why?
| | Food, Fortified | 1 | 2013 | 37 | 0.110 |
Why?
| | Dietary Sucrose | 1 | 2013 | 55 | 0.110 |
Why?
| | Animals | 6 | 2021 | 33381 | 0.110 |
Why?
| | Nutrition Policy | 1 | 2013 | 58 | 0.110 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1323 | 0.110 |
Why?
| | Vitamin A | 1 | 2012 | 55 | 0.110 |
Why?
| | Ferritins | 1 | 2012 | 61 | 0.110 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 56 | 0.110 |
Why?
| | Sweden | 1 | 2012 | 63 | 0.110 |
Why?
| | Maternal Age | 1 | 2012 | 122 | 0.100 |
Why?
| | United States | 4 | 2022 | 12555 | 0.100 |
Why?
| | Vitamin B 12 | 1 | 2012 | 115 | 0.100 |
Why?
| | Folic Acid | 1 | 2012 | 161 | 0.100 |
Why?
| | Signal Transduction | 2 | 2022 | 4709 | 0.100 |
Why?
| | Obesity, Morbid | 1 | 2013 | 197 | 0.100 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2013 | 216 | 0.100 |
Why?
| | Iron | 1 | 2012 | 248 | 0.100 |
Why?
| | Immunization Programs | 1 | 2012 | 206 | 0.090 |
Why?
| | Prevalence | 2 | 2013 | 2326 | 0.090 |
Why?
| | Diet Surveys | 2 | 2021 | 85 | 0.090 |
Why?
| | Zinc | 1 | 2012 | 262 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1171 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2023 | 3171 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2490 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 4708 | 0.080 |
Why?
| | Medicaid | 1 | 2012 | 411 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2674 | 0.080 |
Why?
| | SRS-A | 1 | 1987 | 28 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2022 | 12978 | 0.080 |
Why?
| | Bronchial Provocation Tests | 1 | 1987 | 54 | 0.080 |
Why?
| | Patient Acceptance of Health Care | 1 | 2013 | 687 | 0.080 |
Why?
| | Prednisolone | 1 | 1987 | 76 | 0.080 |
Why?
| | Muscles | 2 | 2022 | 333 | 0.070 |
Why?
| | Mass Screening | 1 | 2013 | 1052 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2024 | 2874 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 1185 | 0.060 |
Why?
| | Child Care | 1 | 2023 | 23 | 0.060 |
Why?
| | Accelerometry | 1 | 2023 | 72 | 0.060 |
Why?
| | Parity | 1 | 2023 | 101 | 0.060 |
Why?
| | Oxylipins | 1 | 2023 | 28 | 0.060 |
Why?
| | Epigenomics | 1 | 2023 | 107 | 0.060 |
Why?
| | Sugars | 1 | 2023 | 32 | 0.060 |
Why?
| | Adipokines | 1 | 2023 | 46 | 0.060 |
Why?
| | Life Style | 2 | 2016 | 430 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6561 | 0.050 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2022 | 16 | 0.050 |
Why?
| | Starch | 1 | 2022 | 24 | 0.050 |
Why?
| | Longevity | 1 | 2023 | 151 | 0.050 |
Why?
| | Menstrual Cycle | 1 | 2022 | 113 | 0.050 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2022 | 167 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 534 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2023 | 299 | 0.050 |
Why?
| | Leukocytes | 1 | 2022 | 290 | 0.050 |
Why?
| | Food | 1 | 2022 | 162 | 0.050 |
Why?
| | Lipase | 1 | 2021 | 70 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 193 | 0.050 |
Why?
| | Dietary Exposure | 1 | 2020 | 7 | 0.050 |
Why?
| | Louisiana | 1 | 2020 | 24 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2022 | 344 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2021 | 152 | 0.050 |
Why?
| | Telomere | 1 | 2022 | 204 | 0.050 |
Why?
| | Genetic Markers | 1 | 2021 | 348 | 0.050 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 110 | 0.050 |
Why?
| | Energy Intake | 1 | 2023 | 447 | 0.050 |
Why?
| | Nutrition Assessment | 1 | 2020 | 78 | 0.050 |
Why?
| | Gene-Environment Interaction | 1 | 2021 | 201 | 0.040 |
Why?
| | CpG Islands | 1 | 2019 | 119 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 693 | 0.040 |
Why?
| | Eating | 1 | 2022 | 369 | 0.040 |
Why?
| | Child Behavior | 1 | 2021 | 212 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3174 | 0.040 |
Why?
| | Public Health | 1 | 2023 | 450 | 0.040 |
Why?
| | Genitalia | 1 | 2018 | 27 | 0.040 |
Why?
| | Edible Grain | 1 | 2018 | 43 | 0.040 |
Why?
| | Particulate Matter | 1 | 2020 | 244 | 0.040 |
Why?
| | Menarche | 1 | 2018 | 51 | 0.040 |
Why?
| | Cities | 1 | 2018 | 96 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2021 | 486 | 0.040 |
Why?
| | Social Class | 1 | 2019 | 218 | 0.040 |
Why?
| | Testis | 1 | 2018 | 144 | 0.040 |
Why?
| | Breast | 1 | 2018 | 140 | 0.040 |
Why?
| | Meat | 1 | 2018 | 89 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2018 | 153 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2018 | 130 | 0.040 |
Why?
| | Lactation | 1 | 2018 | 160 | 0.040 |
Why?
| | Autoimmunity | 1 | 2023 | 831 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 355 | 0.040 |
Why?
| | Adolescent Behavior | 1 | 2021 | 482 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2016 | 70 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 655 | 0.030 |
Why?
| | Oleic Acid | 1 | 2015 | 34 | 0.030 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2015 | 46 | 0.030 |
Why?
| | Linoleic Acid | 1 | 2015 | 41 | 0.030 |
Why?
| | Aged | 1 | 2013 | 19657 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2021 | 1055 | 0.030 |
Why?
| | Vitamin D | 1 | 2018 | 354 | 0.030 |
Why?
| | Research Design | 1 | 2020 | 969 | 0.030 |
Why?
| | Depression | 1 | 2022 | 1132 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2018 | 467 | 0.030 |
Why?
| | Notophthalmus viridescens | 1 | 1993 | 1 | 0.030 |
Why?
| | Radio | 1 | 2013 | 2 | 0.030 |
Why?
| | Salamandridae | 1 | 1993 | 26 | 0.030 |
Why?
| | Tanzania | 1 | 2013 | 45 | 0.030 |
Why?
| | Consumer Health Information | 1 | 2013 | 48 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1244 | 0.030 |
Why?
| | Acclimatization | 1 | 1993 | 135 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2275 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1993 | 536 | 0.030 |
Why?
| | Information Systems | 1 | 2012 | 66 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2062 | 0.030 |
Why?
| | Models, Statistical | 1 | 2014 | 636 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3057 | 0.020 |
Why?
| | Models, Biological | 1 | 2018 | 1715 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 163 | 0.020 |
Why?
| | Rural Population | 1 | 2013 | 452 | 0.020 |
Why?
| | Data Collection | 1 | 2012 | 658 | 0.020 |
Why?
| | Airway Resistance | 1 | 1987 | 33 | 0.020 |
Why?
| | Vaccines | 1 | 2012 | 380 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9342 | 0.020 |
Why?
| | Parents | 1 | 2012 | 1212 | 0.020 |
Why?
| | Quality of Life | 1 | 2013 | 2366 | 0.010 |
Why?
| | Phosphocreatine | 1 | 1993 | 37 | 0.010 |
Why?
| | Phosphates | 1 | 1993 | 167 | 0.010 |
Why?
| | Species Specificity | 1 | 1993 | 565 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1993 | 439 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1993 | 508 | 0.010 |
Why?
| | Temperature | 1 | 1993 | 622 | 0.010 |
Why?
|
|
Perng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|